Improving glycaemic control and life skills in adolescents with type 1 diabetes: A randomised, controlled intervention study using the Guided Self-Determination-Young method in triads of adolescents, parents and health care providers integrated into routine paediatric outpatient clinics

Autor: Esbensen Bente, Thorsteinsson Birger, Husted Gitte R, Hommel Eva, Zoffmann Vibeke

Publikováno v: BMC Pediatrics, Vol 11, Iss 1, p 55 (2011)

Abstract Background Adolescents with type 1 diabetes face demanding challenges due to conflicting priorities between psychosocial needs and diabetes management. This conflict often results in poor glycaemic control and discord between adolescents and

Externí odkaz: https://doaj.org/article/52b2b8e73fbf41ae8ff5f557d318bdad

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Continuous Positive Airway Pressure Treatment for Obstructive Sleep Apnea Does Not Reduce Arterial Stiffness in Patients With Type 2 Diabetes After One Year of Follow-Up

Autor: Krogager, Christoffer, Banghoj, Anne Margareta, Poulsen, Per L., Kirkegaard, Martin G., Thorsteinsson, Birger, Tarnow, Lise, Laugesen, Esben, Hansen, Klavs W.

Publikováno v: Krogager, C, Banghoj, A M, Poulsen, P L, Kirkegaard, M G, Thorsteinsson, B, Tarnow, L, Laugesen, E & Hansen, K W 2021, ' Continuous positive airway pressure treatment for obstructive sleep apnea does not reduce arterial stiffness in patients with type 2 diabetes after one year of follow-up ', Journal of Endocrinology and Metabolism, vol. 11, no. 5, pp. 134-139 . https://doi.org/10.14740/jem773

Background: The aim of this study is to evaluate the effects of 12-month continuous positive airway pressure (CPAP) treatment on arterial stiffness in patients with type 2 diabetes. Methods: Obstructive sleep apnea (OSA) and type 2 diabetes frequentl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::818381638556da4b8ba812298cbb19bf
https://doi.org/10.14740/jem773

CGM-recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia

Autor: Brøsen, Julie Maria Bøggild, Agesen, Rikke Mette, Alibegovic, Amra Ciric, Andersen, Henrik Ullits, Beck-Nielsen, Henning, Gustenhoff, Peter, Hansen, Troels Krarup, Hedetoft, Christoffer Georg Riber, Jensen, Tonny Joran, Stolberg, Charlotte Røn, Juhl, Claus Bogh, Lerche, Susanne Søgaard, Nørgaard, Kirsten, Parving, Hans-Henrik, Tarnow, Lise, Pedersen-Bjergaard, Ulrik, Thorsteinsson, Birger

Publikováno v: Brøsen, J M B, Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C G R, Jensen, T J, Stolberg, C R, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Pedersen-Bjergaard, U & Thorsteinsson, B 2022, ' CGM-recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia ', Diabetes Technology & Therapeutics, vol. 24, no. 9, pp. 643-654 . https://doi.org/10.1089/dia.2021.0567

BACKGROUND AND AIMS: Nocturnal hypoglycemia is mainly a consequence of inappropriate basal insulin therapy in type 1 diabetes (T1D) and may compromise optimal glycemic control. Insulin degludec is associated with a lower risk of nocturnal hypoglycemi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::e5e93f3f928b989eac35131050092ef6
https://pure.au.dk/portal/da/publications/cgmrecorded-hypoglycemia-with-insulin-degludec-or-insulin-glargine-u100-in-people-with-type-1-diabetes-prone-to-nocturnal-severe-hypoglycemia(9f362ed3-529f-4e23-ad2a-d71156e27cb6).html